News

Latest news
October 17, 2026

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programs Latest long-term and real-world data with SKYRIZI®(risankizumab)...

October 13, 2026

Higher rates of endoscopic remission and ulcer-free endoscopy were observed following subcutaneous SKYRIZI® (risankizumab-rzaa)treatment versus placeboi Results build on previously reported week...

October 11, 2026

New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints and...

More »

AbbVie on

Looking for more news from AbbVie? Follow us on social media.

Advanced Search
  • December 06, 2016
    The San Antonio Breast Cancer Symposium, December 6 - 10, brings together academic researchers and health care professionals to share the latest research and advancements in the treatment/understanding of breast cancer.
  • December 02, 2016
    Learn more about the symptoms and treatment of chronic lymphocytic leukemia (CLL).
  • November 29, 2016
    International Medical Corps celebrates its partnership with AbbVie that brings medical, psycho-social and disaster support to vulnerable populations.
  • November 17, 2016
    We are pleased to participate in the National Merit Scholarship Program to recognize outstanding high school students of our employees' families.
  • November 15, 2016
    November is Lung Cancer Awareness Month and as the second most common cancer in both men and women, many people have heard of it, but may not know important facts.
Show 5102550100 per page
Who we are

Get to know the passionate people who make up AbbVie and the difference we strive to make, one patient at a time. Learn more

Sustainability

Our commitment to science is a commitment to better our society. Read our 2025 ESG report

Key Facts

Get a closer look at our impact. 
Learn more

Annual report

See our latest 2025 Annual Report on Form 10-K. Learn more

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?